Personal profile
Research interests
My research focuses on the role of the tumour microenvironment (TME) in tumour progression and metastasis. I am particularly interested in one of its key cellular components, the tumour‑associated macrophages (TAMs). I investigate TAM plasticity, heterogeneity and recruitment to the TME, as well as how distinct TAM subsets evolve during tumour growth and metastatic dissemination. My aim is to identify and characterise tumour‑promoting TAM subsets for predictive and prognostic purposes and to evaluate their potential as therapeutic targets. I also study the diverse effects of cytokines, chemokines and inflammation within the TME. In addition, I am interested in employing 3D models of the TME, including bioprinted systems.
Earlier in my career, I investigated epithelial–mesenchymal transition (EMT) in tumour progression and dissemination, including the induction and regulation of EMT.
Supervisory Interests
I supervise projects that investigate how the tumour microenvironment influences tumour growth and metastasis and how it responds to anti‑cancer therapies. These projects focus on interactions between tumour cells and tumour‑associated macrophages (TAMs), examining macrophage heterogeneity and the emergence of distinct subpopulations during tumour progression and antineoplastic treatment. Pro‑tumoural macrophage subsets are identified and characterised for their potential as therapeutic targets.
My current projects explore TAM plasticity and targeting in various 3D models of the tumour microenvironment, with a particular focus on triple‑negative breast cancer and non‑small cell lung cancer.
Approach to teaching
My academic career has taken me to universities in several countries, where I adopted a range of teaching approaches. At the University of Oxford, I completed two teaching courses focused on interactive and student‑centred learning. At the University of Brighton, I incorporated a variety of digital technologies into my teaching. I hold Fellowship of Advance HE, awarded through the University of Brighton’s accredited CPD scheme.
I value research‑informed teaching and use a blended approach that combines lecture‑theatre delivery with virtual learning environments.
I am Associate Course Leader for the Biomedical Science BSc and MSci courses. As External Examiner, I provide independent oversight of academic standards and assessment quality for an undergraduate Biomedical Science course. My current teaching includes Cellular Pathology (as module leader), Cancer Biology and Immunopharmacology, delivered across the undergraduate and postgraduate Biomedical Science and Biological Sciences programmes, and to medical students.
Knowledge exchange
I am the initiator and lead organiser of the biannual Brighton Tumour Microenvironment Conference which focuses on ECM and stromal–immune interactions, TAMs, TME‑mediated therapy resistance, and therapeutic targeting of the TME.
Education/Academic qualification
Fellow of Advance HE, Advance HE
Award Date: 26 Nov 2018
PhD, Pharmaceutical Sciences, Semmelweis University
Master, Pharmacological Sciences, Semmelweis University
Bachelor, Pharmacology and Pharmacy, Semmelweis University
External positions
External Examiner at London South Bank University
1 Sept 2025 → …
Review Editor in Inflammation, Frontiers in Immunology
27 Aug 2018 → …
Keywords
- RB Pathology
- cancer
- tumour associated macrophages
- inflammation
- metastasis
- 3D models
- Q Science (General)
- chemokines
- cytokines
- epithelial-mesenchymal transition
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation
Huang, L., Wang, J., Wang, X., Zheng, S., Liang, K., Kang, Y. E., Chang, J. W., Koo, B. S., Liu, L., Gal, A. & Shan, Y., 30 Jul 2024, In: Cancer Letters. 601, 217145.Research output: Contribution to journal › Article › peer-review
-
Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target
Tapmeier, T., Howell, J., Zhao, L., Papiez, B. W., Schnabel, J. A., Muschel, R. & Gal, A., 14 Oct 2022, In: Oncogene. 41, 46, p. 5032-5045 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis
Giannos, P., Kechagias, K. & Gal, A., 18 Nov 2021, In: Biology. 10, 11, 1200.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Targeting tumour associated macrophages in anti-cancer therapies
Gal, A., 5 Jan 2018, p. 0-0. 1 p.Research output: Contribution to conference › Other
-
Plasticity of macrophages in the tumour microenvironment
Gal, A., 12 Dec 2017, p. 0-0. 1 p.Research output: Contribution to conference › Other
-
PLASTICITY OF TUMOUR ASSOCIATED MACROPHAGES IN PULMONARY METASTASIS
Gal, A. (Presenter)
7 May 2025Activity: External talk or presentation › Invited talk
-
The Brighton Tumour Microenvironment Conference
Gal, A. (Organiser)
21 Oct 2024 → 22 Oct 2024Activity: Events › Conference
-
British Society for Immunology (External organisation)
Gal, A. (Member)
7 Dec 2023Activity: External boards and professional/academic bodies › Membership of professional body
-
Institute of Biomedical Science (External organisation)
Gal, A. (Fellow)
1 Apr 2023Activity: External boards and professional/academic bodies › Membership of professional body
-
The Higher Education Academy (HEA) (External organisation)
Gal, A. (Fellow)
21 Nov 2018Activity: External boards and professional/academic bodies › Membership of professional body